Transplantation, AutologousPeripheral Blood Stem Cell TransplantationBone Marrow TransplantationHematopoietic Stem Cell TransplantationTransplantation, HomologousTransplantation ConditioningCombined Modality TherapyHematopoietic Stem Cell MobilizationMelphalanCyclophosphamideAntineoplastic Combined Chemotherapy ProtocolsGranulocyte Colony-Stimulating FactorLymphoma, Non-HodgkinHematologic NeoplasmsAntigens, CD34Graft vs Host DiseaseStem Cell TransplantationLeukapheresisBone Marrow PurgingBusulfanCarmustineHematopoietic Stem CellsBone MarrowTreatment OutcomeBlood Component RemovalEtoposideMultiple MyelomaGraft SurvivalWhole-Body IrradiationRemission InductionRecurrenceStem CellsMyeloablative AgonistsThiotepaHodgkin DiseaseCytarabineBone Marrow CellsAntineoplastic Agents, AlkylatingHematopoiesisSalvage TherapyVincristineDisease-Free SurvivalTransplantation ChimeraLeukemia, Myeloid, AcuteSurvival AnalysisTissue DonorsLeukemiaCord Blood Stem Cell TransplantationSurvival RateIfosfamideTime FactorsRetrospective StudiesCytophagocytosisHistocompatibility TestingNeoplasmsDoxorubicinHistocompatibilityTransplantation, IsogeneicAmyloidosisPlatelet CountFollow-Up StudiesBlood Cell CountLymphomaPrednisonePrecursor Cell Lymphoblastic Leukemia-LymphomaAnemia, AplasticImmunosuppressive AgentsCarboplatinInfectionAntineoplastic AgentsBone Marrow DiseasesLiver TransplantationColony-Forming Units AssayProspective StudiesRecombinant ProteinsMyelodysplastic SyndromesLymphoma, T-CellDexamethasoneLeukemia, MyeloidLeukemia, Myelogenous, Chronic, BCR-ABL PositivePrognosisHematologic DiseasesT-LymphocytesLeukocyte CountPodophyllotoxinPOEMS SyndromeCytomegalovirus InfectionsAcute DiseaseGraft vs Leukemia EffectLymphocyte DepletionVidarabineImmunosuppressionFatal OutcomeBlood CellsCyclosporineMesenchymal Stem Cell TransplantationCell SeparationImmunophenotypingFeasibility StudiesHLA Antigens